Mechanisms and functions of serotonin neuronal systems: Opportunities for neuropeptide interactions

Annals of the New York Academy of Sciences

Volumn 780, Issue , 1996, Pages 176-184

  Fuller, Ray W ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; GRANISETRON; NEUROPEPTIDE; NEUROTRANSMITTER; ONDANSETRON; PAROXETINE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUMATRIPTAN;

CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DEPRESSION; HUMAN; MIGRAINE; NAUSEA; OBESITY; PEPTIDERGIC NERVOUS SYSTEM; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; VOMITING;

EID: 0029970063     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb15122.x     Document Type: Article

References (61)

1. HILLARP, N. A., K. FUXE & A. DAHLSTROM. 1966. Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol. Rev. 18(1): 727-741.
2. FISHER, L. A. 1989. Corticotropin-releasing factor: Endocrine and autonomic integration of responses to stress. Trends Pharmacol. Sci. 10: 189-193.
3. WOODS, S. C. & J. GIBBS. 1989. The regulation of food intake by peptides. Ann. N.Y. Acad. Sci. 575: 236-245.
4. CARR, D. B. & A. W. LIPKOWSKI. 1990. Neuropeptides and pain. Aggressologie 31(4): 173-177.
5. COOPER, S. J., C. T. DOURISH & P. G. CLIFTON. 1992. CCK antagonists and CCK-monoamine interactions in the control of satiety. Am. J. Clin. Nutr. 55(1 Suppl): 291S-295S.
6. JOHNSON, H. M., M. O. DOWNS & C. H. PONTZER. 1992. Neuroendocrine peptide hormone regulation of immunity. Chem. Immunol. 52: 49-83.
7. EDVINSSON, L. & P. J. GOADSBY. 1994. Neuropeptides in migraine and cluster headache. Cephalalgia 14(5): 320-327.
8. JACOBS, B. L. & E. C. AZMITIA. 1992. Structure and function of the brain serotonin system. Physiol. Rev. 72(1): 165-229.
9. ASBERG, M., B. ERIKSSON, B. MARTENSSON, L. TRASKMAN-BENDZ & A. WAGNER. 1986. Therapeutic effects of serotonin uptake inhibitors in depression. J. Clin. Psychiatry 47(4): 23-35.
10. LESTER, D. 1995. The concentration of neurotransmitter metabolites in the cerebrospinal-fluid of suicidal individuals - a metaanalysis. Pharmacopsychiatry 28(2): 45-50.
11. BROWN, G. L. & M. I. LINNOILA. 1990. CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J. Clin. Psychiatry 54(4): 31-41.
12. EICHELMAN, B. S. 1990. Neurochemical and psychopharmacologic aspects of aggressive behavior. Annu. Rev. Med. 41: 149-158.
13. DESCARRIES, L., M. A. AUDET, G. DOUCET, S. GARCIA, S. OLESKEVICH, P. SÉQUÉLA, J.-J. SOGHOMONIAN & K. C. WATKINS. 1990. Morphology of central serotonin neurons: Brief review of quantified aspects of their distribution and ultrastructural relationships. Ann. N. Y. Acad. Sci. 600: 81-92.
14. TÖRK, I. 1990. Anatomy of the serotonergic system. Ann. N.Y. Acad. Sci. 600: 9-35.
15. MAMOUNAS, L. A., C. A. MULLEN, E. O'HEARN & M. E. MOLLIVER. 1991. Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol. 314(3): 558-586.
16. FULLER, R. W. 1995. Serotonin uptake inhibitors: Uses in clinical therapy and in laboratory research. In Progress in Drug Research. E. Jucker, Ed.: Vol. 45: 167-204. Birkhäuser-Verlag. Basel.
17. PLOSKER, G. L. & D. MCTAVISH. 1994. Sumatriptan - a reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 94(4): 622-651.
18. DILLY, S. 1994. Overview of clinical experience with new 5-HT3-receptor antagonists. Hosp. Formul. 29(S5): S10-S17.
19. MCTAVISH, D. & R. C. HEEL. 1992. Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity. Drugs 43(5): 713-733.
20. TAYLOR, D. P. & S. L. MOON. 1991. Buspirone and related compounds as alternative anxiolytics. Neuropeptides 19(Suppl): 15-19.
21. MOSKOWITZ, M. A. & F. M. CUTRER. 1993. Sumatriptan: A receptor-targeted treatment for migraine. Annu. Rev. Med. 44: 145-154.
22. COOPER, S. J., C. T. DOURISH & D. J. BARBER. 1990. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329. Br. J. Pharmacol. 99(1): 65-70.
23. ROWLAND, N. E. 1994. Tolerance to the anorectic effect of dexfenfluramine in rats: Role of serotonin, cholecystokinin, and neuropeptide Y. Physiol. Behav. 55(2): 201-207.
24. GADDUM, J. H. & Z. P. PICARELLI. 1957. Two kinds of tryptamine receptor. Br. J. Pharmacol. 123: 323-328.
25. 3H]spiroperidol. Mol. Pharmacol. 16: 687-699.
26. HOYER, D., D. E. CLARKE, J. R. FOZARD, P. R. HARTIG, G. R. MARTIN, E. J. MYLECHARANE, P. R. SAXENA & P. P. A. HUMPHREY. 1994. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46(2): 157-203.
27. FULLER, R. W. 1994. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55(3): 163-167.
28. REIS, L. C., M. J. RAMALHO, A. L. V. FAVARETTO, J. GUTKOWSKA, S. M. MCCANN & J. ANTUNESRODRIGUES. 1994. Participation of the ascending serotonergic system in the stimulation of atrial-natriuretic-peptide release. Proc. Natl. Acad. Sci. USA 91(25): 12022-12026.
29. BENDOTTI, C., G. TARIZZO, F. FUMAGALLI, S. BALDESSARI & R. SAMANIN. 1993. Increased expression of preproneuropeptide Y and preprosomatostatin mRNA in striatum after selective serotoninergic lesions in rats. Neurosci. Lett. 160(2): 197-200.
30. HISANO, S., M. CHIKAMORI-AOYAMA, S. KATOH, M. MAEGAWA & S. DAIKOKU. 1987. Immunohistochemical evidence of serotoninergic regulation of vasoactive intestinal polypeptide (VIP) in the rat suprachiasmatic nucleus. Histochemistry 86(6): 573-578.
31. GUY, J., G. PELLETIER & O. BOSLER. 1988. Serotonin innervation of neuropeptide Y-containing neurons in the rat arcuate nucleus. Neurosci. Lett. 85(1): 9-13.
32. COSTA, J. J. L., S. AVERILL, J. P. SAAVEDRA & J. V. PRIESTLEY. 1994. Serotonin innervation of enkephalin-containing neurons in the rat spinal trigeminal nucleus. Neurosci. Lett. 168(1-2): 167-171.
33. LIPOSITS, Z., C. PHELIX & W. K. PAULL. 1987. Synaptic interactions of serotonergic axons and corticotrophin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 86(6): 541-549.
34. FULLER, R. W. 1992. The involvement of serotonin in regulation of pituitary-adrenocortical function. Front. Neuroendocrinol. 13(3): 250-270.
35. GIBBS, D. M. & W. VALE. 1983. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophyseal portal blood. Brain Res. 280(1): 176-179.
36. CALOGERO, A. E., R. BERNARDINI, A. N. MARGIORIS, G. BAGDY, W. T. GALLUCCI, P. J. MUNSON, L. TAMARKIN, T. P. TOMAI, L. BRADY, P. W. GOLD & G. P. CHROUSOS. 1989. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides 10(1): 189-200.
37. SAPHIER, D., J. E. WELCH, G. E. FARRAR, N. Q. NGUYEN, F. AGUADO, T. R. THALLER & D. S. KNIGHT. 1994. Interactions between serotonin, thyrotropin-releasing hormone, and substance P in the CNS regulation of adrenocortical secretion. Psychoneuroendocrinology 19(8): 779-797.
38. PHELIX, C. F., Z. LIPOSITS & W. K. PAULL. 1992. Serotonin-CRF interaction in the bed nucleus of the stria terminalis: A light microscopic double-label immunocytochemical analysis. Brain Res. Bull. 28(6): 943-948.
39. DEDEOGLU, A. & L. A. FISHER. 1994. Cardiovascular activation by serotonergic stimulation: Role of corticotropin-releasing factor. Am. J. Physiol. 267(3 Pt 2): R859-R864.
40. LE FEUVRE, R. A., L. AISENTHAL & N. J. ROTHWELL. 1991. Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds. Brain Res. 555(2): 245-250.
41. SHIMIZU, H. & G. A. BRAY. 1989. Modulation by corticotropin-releasing factor of monoamine metabolism in the lateral hypothalamus. Neurosci. Lett. 103(1): 74-80.
42. BOADLE-BIBER, M. C., V. B. SINGH, K. C. CORLEY, T. H. PHAN & R. P. DILTS. 1993. Evidence that corticotropin-releasing factor within the extended amygdala mediates the activation of tryptophan hydroxylase produced by sound stress in the rat. Brain Res. 628(1-2): 105-114.
43. FUXE, K., S.-O. OGREN, A. JANSSON, A. CINTRA, A. HARFSTRAND & L. F. AGNATI. 1988. Intraventricular injection of galanin reduces 5-HT metabolism in the ventral limbic cortex, the hippocampal formation and the fronto-parietal cortex of the male rat. Acta Physiol. Scand. 133(4): 579-581.
44. 3H]5-hydroxytryptamine from rat hypothalamic synaptosomal preparations. Neurosci. Lett. 122(1): 87-90.
45. SCHLICKER, E., G. GROSS, K. FINK, T. GLASER & M. GOTHERT. 1991. Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH 1-24, angiotensin II, bradykinin and delta-sleep-inducing peptide. Naunyn-Schmiedebergs Arch. Pharmakol. 343(2): 117-122.
46. BRENT, P. J., L. A. CHAHL & P. A. CANTARELLA. 1994. Effects of intracerebroventricular injection of substance P on biogenic amine concentrations in guinea-pig brain. Biog. Amines 10(4): 319-327.
47. KENDRICK, K., G. LENG & T. HIGUCHI. 1991. Noradrenaline, dopamine and serotonin release in the paraventricular and supraoptic nuclei of the rat in response to intravenous cholecystokinin injections. J. Neuroendocrinol. 3: 139-144.
48. STALLONE, D., S. NICOLAIDIS & J. GIBBS. 1989. Cholecystokinin-induced anorexia depends on serotonergic function. Am. J. Physiol. 256(5 Pt 2): R1138-R1141.
49. GRIGNASCHI, G., B. MANTELLI, C. FRACASSO, M. ANELLI, S. CACCIA & R. SAMANIN. 1993. Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats. Br. J. Pharmacol. 109(2): 491-494.
50. 1C receptors. Am. J. Physiol. 264(1 Pt 2): R62-R64.
51. ESFAHANI, N., I. BEDNAR, G. A. QURESHI & P. SODERSTEN. 1995. Inhibition of serotonin synthesis attenuates inhibition of ingestive behavior by CCK-8. Pharmacol. Biochem. Behav. 51(1): 9-12.
52. EBENEZER, I. S. & J. BROOMAN. 1994. Pretreatment with the 5-HT1A receptor agonists 8-OH-DPAT or gepirone does not attenuate the inhibitory effect of systemically administered cholecystokinin (CCK) on food-intake in rats. Methods Find. Exp. Clin. Pharmacol. 16(8): 589-595.
53. BEITZ, A. J., R. D. SHEPARD & W. E. WELLS. 1983. The periaqueductal gray-raphe magnus projection contains somatostatin, neurotensin and serotonin but not cholecystokinin. Brain Res. 261(1): 132-137.
54. MELANDER, T., T. HOKFELT, A. ROKAEUS, A. C. CUELLO, W. H. OERTEL, A. VERHOFSTAD & M. GOLDSTEIN. 1986. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J. Neurosci. 6(12): 3640-3654.
55. CHIBA, T. & S. MASUKO. 1989. Coexistence of varying combinations of neuropeptides with 5-hydroxytryptamine in neurons of the raphe pallidus et obscurus projecting to the spinal cord. Neurosci. Res. 7(1): 13-23.
56. MILHORN, D. E., T. HOKFELT, A. A. VERHOFSTAD & L. TERENIUS. 1989. Individual cells in the raphe nuclei of the medulla oblongata in rat that contain immunoreactivities for both serotonin and enkephalin project to the spinal cord. Exp. Brain Res. 75(3): 536-542.
57. ARVIDSSON, U., M. SCHALLING, S. CULLHEIM, B. ULFHAKE, L. TERENIUS, A. VERHOFSTAD & T. HOKFELT. 1990. Evidence for coexistence between calcitonin gene-related peptide and serotonin in the bulbospinal pathway in the monkey. Brain Res. 532(1-2): 47-57.
58. SASEK, C. A., M. W. WESSENDORF & C. J. HELKE. 1990. Evidence for coexistence of thyrotropin-releasing hormone, substance P and serotonin in ventral medullary neurons that project to the intermediolateral cell column in the rat. Neurosci. 35(1): 105-119.
59. FUNG, S. J., V. K. REDDY, H. ZHUO, R. H. LIU & C. D. BARNES. 1994. Bulbospinal neurons of the cat that co-contain serotonin and methionine-enkephalin. Arch. Ital. Biol. 132(2): 61-72.
60. NEVIN, K., H. ZHUO & C. J. HELKE. 1994. Neurokinin A coexists with substance P and serotonin in ventral medullary spinally projecting neurons of the rat. Peptides 15(6): 1003-1011.
61. 1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the rat. Brain Res. 560(1-2): 251-259.